Key facts
| Price (PPV) | 203 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | azilsartan medoxomilchlorthalidone |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA09 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Boite de 28 |
| Hospital price | 127.10 MAD |
| Data collected on | 9/8/2026 |
Indications
Edarbyclor est indiqué dans la prise en charge de l'hypertension lorsque le traitement avec un seul des deux principes actifs ne suffit pas.
Find an open pharmacy
On-call pharmacies near you
About Edarbyclor 40 mg / 25 mg
Edarbyclor 40 mg / 25 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Edarbyclor 40 mg / 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Edarbyclor 40 mg / 25 mg
Answers to common questions from Moroccan patients about this drug.